Borrelia pathogenesis research in the post-genomic and post-vaccine era

Curr Opin Microbiol. 2000 Feb;3(1):86-92. doi: 10.1016/s1369-5274(99)00056-9.

Abstract

In the two years after publication of the genome sequence of Borrelia burgdorferi and reports on human field trials of a vaccine against Lyme borreliosis, there has been further progress in understanding of host-parasite interactions during Lyme borreliosis and relapsing fever. Some mechanisms that Borrelia spirochetes use to avoid elimination and to persist in the host are novel. In addition, the recent discovery of antigenic variation in the Lyme disease agent B. burgdorferi adds to the complexity of the possible virulence properties of this human pathogen.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Bacterial Vaccines
  • Borrelia / genetics
  • Borrelia / immunology
  • Borrelia / pathogenicity*
  • Borrelia Infections / immunology
  • Borrelia Infections / microbiology*
  • Borrelia Infections / pathology
  • Genome, Bacterial
  • Humans
  • Mice
  • Virulence

Substances

  • Bacterial Vaccines